Articles in Scholarly Journals [Incomplete List]

1. Increased tau protein differentiates mild cognitive impairment from geriatric depression and predicts conversion to dementia
   Neuroscience Letters, vol. 416, no. 1, pp. 39–42, 2007
2. Structural Changes of the Corpus Callosum in Mild Cognitive Impairment and Alzheimer’s Disease
   Dementia and Geriatric Cognitive Disorders, vol. 21, no. 4, pp. 215–220, 2006
3. Kommunikations-TAnDem
   Zeitschrift für Gerontologie und Geriatrie, vol. 39, no. 5, pp. 358–364, 2006
4. Reduced cerebellar volume and neurological soft signs in first-episode schizophrenia
   Psychiatry Research: Neuroimaging, vol. 140, no. 3, pp. 239–250, 2005
5. Diagnostic Value of FDG-PET and HMPAO-SPET in Patients with Mild Dementia and Mild Cognitive Impairment: Metabolic Index and Perfusion Index
   Dementia and Geriatric Cognitive Disorders, vol. 20, no. 2-3, pp. 63–70, 2005
6. Psychiatric symptoms in alpha-mannosidosis
   Journal of Intellectual Disability Research, vol. 49, no. 11, pp. 865–871, 2005
7. Neuropsychologische Profile in der Demenzdiagnostik: Eine Untersuchung mit der CERAD-NP-Testbatterie
   Fortschritte der Neurologie · Psychiatrie, vol. 73, no. 10, pp. 568–576, 2005
8. Prevalence and Natural Course of Aging-Associated Cognitive Decline in a Population-Based Sample of Young-Old Subjects
   American Journal of Psychiatry, vol. 162, no. 11, pp. 2071–2077, 2005
9. Neuropsychologische Korrelate zerebraler Atrophie bei der Alzheimer-Demenz
   Fortschritte der Neurologie · Psychiatrie, vol. 72, no. 4, pp. 192–203, 2004
10. Distribution of cerebral atrophy assessed by magnetic resonance imaging reflects patterns of neuropsychological deficits in Alzheimer's dementia*1
    Neuroscience Letters, vol. 361, no. 1-3, pp. 17–20, 2004
11. MRI-morphometric changes in first-episode schizophrenic patients at 14 months follow-up
    Schizophrenia Research, vol. 67, no. 2-3, pp. 301–303, 2004
12. Levels of total tau and tau protein phosphorylated at threonine 181 in patients with incipient and manifest Alzheimer's disease
    Neuroscience Letters, vol. 339, no. 2, pp. 172–174, 2003
13. Cerebrospinal fluid tau levels in Alzheimer's disease are elevated when compared with vascular dementia but do not correlate with measures of cerebral atrophy
    Psychiatry Research, vol. 120, no. 3, pp. 231–238, 2003
14. Corpus callosum in first-episode patients with schizophrenia a magnetic resonance imaging study
    Psychological Medicine, vol. 33, no. 6, pp. 1019–1027, 2003
15. Parahippocampal Volume Deficits in Subjects With Aging-Associated Cognitive Decline
    American Journal of Psychiatry, vol. 160, no. 2, pp. 379–382, 2003
16. Die Magnetresonanztomographie in der klinischen Demenzdiagnostik
    Der Radiologe, vol. 43, no. 7, pp. 513–520, 2003
17. Strukturelle zerebrale Veränderungen bei Probanden mit leichter kognitiver Beeinträchtigung
    Der Nervenarzt, vol. 73, no. 9, pp. 845–850, 2002
18. Progressive medial temporal lobe changes in Alzheimer's disease revealed by quantitative MRI: potential use for monitoring of drug-related changes
    Drug Development Research, vol. 56, no. 2, pp. 51–56, 2002
19. Cerebrospinal fluid 24S-hydroxycholesterol is increased in patients with Alzheimer's disease compared to healthy controls
    Neuroscience Letters, vol. 324, no. 1, pp. 83–85, 2002
20. Reduced cerebrospinal fluid estradiol levels are associated with increased ß-amyloid levels in female patients with Alzheimer's disease
    Neuroscience Letters, vol. 307, no. 2, pp. 122–124, 2001
21. Frontotemporal dementia: clinical, neuroimaging, and molecular biological findings in 6 patients
    European Archives of Psychiatry and Clinical Neuroscience, vol. 251, no. 5, pp. 225–231, 2001
22. Die quantitative Magnetresonanztomographie in der Diagnostik der Alzheimer-Demenz
    Zeitschrift f�r Gerontologie und Geriatrie, vol. 34, no. 2, pp. 101–107, 2001
23. A new method for the in vivo volumetric measurement of the human hippocampus with high neuroanatomical accuracy
    Hippocampus, vol. 10, no. 6, pp. 752–758, 2000
24. G-CSF plasma levels in clozapine-induced neutropenia
    Biological Psychiatry, vol. 48, no. 11, pp. 1113–1115, 2000
25. Tau-Protein-Spiegel in der Diagnostik der Alzheimer-Demenz
    Fortschritte der Neurologie · Psychiatrie, vol. 68, no. 10, pp. 439–446, 2000
26. Syntactic Comprehension Deficits in Alzheimer's Disease
    Brain and Language, vol. 71, no. 3, pp. 432–448, 2000
27. Cerebrospinal fluid A?42 is increased early in sporadic Alzheimer's disease and declines with disease progression
    Annals of Neurology, vol. 45, no. 4, pp. 504–511, 1999
28. Über die Evaluation von Forschungsleistungen in der Psychiatrie
    Der Nervenarzt, vol. 70, no. 3, pp. 281–287, 1999
29. Topography of callosal atrophy reflects distribution of regional cerebral volume reduction in Alzheimer's disease
    Psychiatry Research: Neuroimaging, vol. 90, no. 3, pp. 181–192, 1999
30. In vivo Quantification of Brain Volumes in Subcortical Vascular Dementia and Alzheimer’s Disease
    Dementia and Geriatric Cognitive Disorders, vol. 9, no. 6, pp. 309–316, 1998
31. Leichte kognitive Beeinträchtigung im Alter
    Der Nervenarzt, vol. 69, no. 11, pp. 975–982, 1998
32. Hirnvolumetrische Befunde bei der Spätdepression
    Der Nervenarzt, vol. 69, no. 11, pp. 968–974, 1998
33. Quantitative magnetic resonance imaging and neuropsychological functions in dementia of the Alzheimer type
    Psychological Medicine, vol. 27, no. 1, pp. 221–229, 1997
34. Quantitative magnetic resonance imaging in geriatric depression and primary degenerative dementia
    Journal of Affective Disorders, vol. 42, no. 1, pp. 69–83, 1997
35. Analysis of Heterogeneous beta A4 Peptides in Human Cerebrospinal Fluid and Blood by a Newly Developed Sensitive Western Blot Assay
    Journal of Biological Chemistry, vol. 271, no. 37, pp. 22908–22914, 1996
36. Immunochemical mapping of human lutropin: II. Characterization of two monoclonal antipeptide antibodies reacting with the native ß-subunit
    Molecular and Cellular Endocrinology, vol. 101, no. 1-2, pp. 21–28, 1994